Selective protein degradation by ligand-targeted enzymes: Towards the creation of catalytic antagonists

被引:14
作者
Davis, BG
Sala, RF
Hodgson, DRW
Ullman, A
Khumtaveeporn, K
Estell, DA
Sanford, K
Bott, RR
Jones, JB
机构
[1] Univ Oxford, Dyson Perrins Lab, Dept Chem, Oxford OX1 3QY, England
[2] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada
[3] Genencor Int, Palo Alto, CA 94304 USA
基金
英国生物技术与生命科学研究理事会;
关键词
affinity cleavage; enzymes; protein design; receptors; selectivity;
D O I
10.1002/cbic.200300591
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular angler fish: By precisely positioning different binding ligands (L) around the active site "mouth" of a degradative proteinase enzyme, target proteins (TP) can be plucked from solution, locked in position adjacent to the catalytic triad "jaws", and in this way readily and specifically degraded (see scheme). In this strategy, the appropriate ligand acts as a homing device to confer and enhance selectivity, in the best case by more than 350-fold, in a generic process that exploits the intrinsic, ligand-recognition capabilities of the protein target to trigger its own destruction. The hunting strategy of the deep sea Angler Fish, which uses a lure above its mouth, illustrates this principle.
引用
收藏
页码:533 / +
页数:6
相关论文
共 23 条
[1]   AFFINITY CLEAVAGE AND TARGETED CATALYSIS OF PROTEINS USING THE AVIDIN BIOTIN SYSTEM [J].
BAYER, EA ;
GROOTJANS, JJ ;
ALON, R ;
WILCHEK, M .
BIOCHEMISTRY, 1990, 29 (51) :11274-11279
[2]   Chemical modification of cysteine mutants of subtilisin Bacillus lentus can create better catalysts than the wild-type enzyme [J].
Berglund, P ;
DeSantis, G ;
Stabile, MR ;
Shang, X ;
Gold, M ;
Bott, RR ;
Graycar, TP ;
Lau, TH ;
Mitchinson, C ;
Jones, JB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (22) :5265-5266
[3]   CRYSTAL-STRUCTURE OF THE ALKALINE PROTEINASE SAVINASE FROM BACILLUS-LENTUS AT 1.4-A RESOLUTION [J].
BETZEL, C ;
KLUPSCH, S ;
PAPENDORF, G ;
HASTRUP, S ;
BRANNER, S ;
WILSON, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 223 (02) :427-445
[4]   The pharmacological basis of anti-IgE therapy [J].
Chang, TW .
NATURE BIOTECHNOLOGY, 2000, 18 (02) :157-162
[5]   Protease-activated receptors: sentries for inflammation? [J].
Cocks, TM ;
Moffatt, JD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :103-108
[6]   Glycomethanethiosulfonates: powerful reagents for protein glycosylation [J].
Davis, BG ;
Maughan, MAT ;
Green, MP ;
Ullman, A ;
Jones, JB .
TETRAHEDRON-ASYMMETRY, 2000, 11 (01) :245-262
[7]   Chemical modification of enzymes for enhanced functionality [J].
DeSantis, G ;
Jones, JB .
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (04) :324-330
[8]   Site-directed mutagenesis combined with chemical modification as a strategy for altering the specificity of the S1 and S1′ pockets of subtilisin Bacillus lentus [J].
DeSantis, G ;
Berglund, P ;
Stabile, MR ;
Gold, M ;
Jones, JB .
BIOCHEMISTRY, 1998, 37 (17) :5968-5973
[9]   Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides [J].
Galili, U ;
Matta, KL .
TRANSPLANTATION, 1996, 62 (02) :256-262
[10]  
GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5